Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication
Pruthvi Gowda, Shruti Patrick, Shanker Datt Joshi, Rajesh Kumawat, Ellora Sen
Topics & Concepts
GlycyrrhizinHMGB1Replication (statistics)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)VirologyHigh-mobility groupViral replication2019-20 coronavirus outbreakChemistryMedicineImmunologyPharmacologyVirusBiochemistryInternal medicineInflammationOutbreakInfectious disease (medical specialty)GeneDiseaseAdvanced Glycation End Products researchCOVID-19 Clinical Research StudiesInflammasome and immune disorders